Patents Assigned to Evoke Pharma, Inc.
  • Nasal formulations of metoclopramide
    Patent number: 11813231
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: November 14, 2023
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Nasal formulations of metoclopramide
    Patent number: 11628150
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: April 18, 2023
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • Treatment of moderate and severe gastroparesis
    Patent number: 11517545
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: December 6, 2022
    Assignee: EVOKE Pharma, Inc.
    Inventors: Marilyn R. Carlson, Matthew J. D'Onofrio, David A. Gonyer, Wayne Alves
  • Nasal formulations of metoclopramide
    Patent number: 11020361
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 1, 2021
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
  • NASAL FORMULATIONS OF METOCLOPRAMIDE
    Publication number: 20130213393
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Application
    Filed: October 25, 2012
    Publication date: August 22, 2013
    Applicant: EVOKE PHARMA, INC.
    Inventor: Evoke Pharma, Inc.
  • TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS
    Publication number: 20130217775
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: August 23, 2012
    Publication date: August 22, 2013
    Applicant: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Marilyn R. Carlson
  • Nasal formulations of metoclopramide
    Patent number: 8334281
    Abstract: Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: December 18, 2012
    Assignee: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden